How it works

DASABAY 50 contains the active ingredient Dasatinib. Dasatinib is a medication used in the treatment of certain types of cancer, particularly chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It works by inhibiting specific proteins (tyrosine kinases) that are involved in the growth and proliferation of cancer cells. By blocking these proteins, Dasatinib helps slow down or stop the growth of cancer cells and may induce remission.

‍Indications

DASABAY 50 is typically prescribed for the following conditions:
1. Chronic myeloid leukemia (CML): It is used in the treatment of CML in patients who have not responded to other therapies or have developed resistance.
2. Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL): Dasatinib is used in the treatment of Ph+ ALL in patients who are not responding to other treatments.

Dosage

The dosage of DASABAY 50 will vary depending on the specific condition being treated, the patient's overall health, and the doctor's recommendations.
It is typically taken orally, usually once daily.
Follow your healthcare provider's instructions regarding the dosage and duration of treatment.

Side Effects

DASABAY 50 may cause side effects in some individuals. Common side effects may include:
1. Nausea
2. Diarrhea
3. Headache
4. Fatigue
5. Rash
6. Swelling of the ankles and legs
7. Low blood counts (anemia, low platelets, low white blood cell count)
8. Elevated liver enzymes

Contraindication

DASABAY 50 should not be used in certain situations, including:
1. Hypersensitivity or allergy to Dasatinib or any other components of the medication.
2. It should not be used in pregnant women, as it can harm the unborn baby.